MBA Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04M | Sell |
5,625
-215
| -4% | -$39.9K | 0.48% | 49 |
|
|
2025
Q1 | $1.22M | Buy |
5,840
+96
| +2% | +$20.1K | 0.61% | 37 |
|
|
2024
Q4 | $1.02M | Sell |
5,744
-486
| -8% | -$86.4K | 0.51% | 46 |
|
|
2024
Q3 | $1.23M | Buy |
6,230
+12
| +0.2% | +$2.37K | 0.59% | 43 |
|
|
2024
Q2 | $1.07M | Buy |
6,218
+495
| +9% | +$84.9K | 0.55% | 45 |
|
|
2024
Q1 | $1.04M | Sell |
5,723
-423
| -7% | -$77K | 0.54% | 48 |
|
|
2023
Q4 | $952K | Sell |
6,146
-135
| -2% | -$20.9K | 0.53% | 47 |
|
|
2023
Q3 | $936K | Buy |
6,281
+19
| +0.3% | +$2.83K | 0.57% | 45 |
|
|
2023
Q2 | $844K | Buy |
6,262
+41
| +0.7% | +$5.52K | 0.5% | 48 |
|
|
2023
Q1 | $991K | Buy |
6,221
+169
| +3% | +$26.9K | 0.62% | 47 |
|
|
2022
Q4 | $978K | Buy |
6,052
+198
| +3% | +$32K | 0.64% | 43 |
|
|
2022
Q3 | $786K | Buy |
5,854
+604
| +12% | +$81.1K | 0.57% | 47 |
|
|
2022
Q2 | $804K | Sell |
5,250
-83
| -2% | -$12.7K | 0.55% | 51 |
|
|
2022
Q1 | $864K | Sell |
5,333
-786
| -13% | -$127K | 0.54% | 54 |
|
|
2021
Q4 | $828K | Buy |
6,119
+651
| +12% | +$88.1K | 0.51% | 54 |
|
|
2021
Q3 | $590K | Buy |
5,468
+61
| +1% | +$6.58K | 0.44% | 64 |
|
|
2021
Q2 | $609 | Sell |
5,407
-366
| -6% | -$41 | 0.28% | 62 |
|
|
2021
Q1 | $625 | Buy |
+5,773
| New | +$625 | 0.34% | 59 |
|